110 related articles for article (PubMed ID: 11949893)
1. Cardiac effects of a selective rho-associated kinase inhibitor, Y-27632, assessed in canine isolated, blood-perfused heart preparations.
Sugiyama A; Yatomi Y; Takahara A; Satoh Y; Hashimoto K
Jpn J Pharmacol; 2002 Mar; 88(3):359-61. PubMed ID: 11949893
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of Y-27632, a selective Rho-associated kinase inhibitor, assessed in the halothane-anesthetized canine model.
Takahara A; Sugiyama A; Satoh Y; Yoneyama M; Hashimoto K
Eur J Pharmacol; 2003 Jan; 460(1):51-7. PubMed ID: 12535859
[TBL] [Abstract][Full Text] [Related]
3. Constitutional rho-kinase regulates atrioventricular nodal conduction and ventricular repolarization of the canine heart.
Sugiyama A; Takahara A; Yatomi Y; Satoh Y; Nakamura Y; Hashimoto K
J Cardiovasc Pharmacol; 2003 Jun; 41(6):930-3. PubMed ID: 12775972
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of agonist-induced positive inotropy by a selective Rho-associated kinase inhibitor, Y-27632.
Nishimaru K; Tanaka Y; Tanaka H; Shigenobu K
J Pharmacol Sci; 2003 Aug; 92(4):424-7. PubMed ID: 12939528
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.
Ishizaki T; Uehata M; Tamechika I; Keel J; Nonomura K; Maekawa M; Narumiya S
Mol Pharmacol; 2000 May; 57(5):976-83. PubMed ID: 10779382
[TBL] [Abstract][Full Text] [Related]
6. Y-27632, a Rho-kinase inhibitor, inhibits proliferation and adrenergic contraction of prostatic smooth muscle cells.
Rees RW; Foxwell NA; Ralph DJ; Kell PD; Moncada S; Cellek S
J Urol; 2003 Dec; 170(6 Pt 1):2517-22. PubMed ID: 14634463
[TBL] [Abstract][Full Text] [Related]
7. Effects of Y-27632 on acetylcholine-induced contraction of intact and permeabilized intrapulmonary bronchial smooth muscles in rats.
Chiba Y; Takeyama H; Sakai H; Misawa M
Eur J Pharmacol; 2001 Sep; 427(1):77-82. PubMed ID: 11553366
[TBL] [Abstract][Full Text] [Related]
8. Rho-kinase (ROCK-1 and ROCK-2) upregulation in oleic acid-induced lung injury and its restoration by Y-27632.
Köksel O; Yildirim C; Tiftik RN; Kubat H; Tamer L; Cinel L; Kaplan MB; Değirmenci U; Ozdülger A; Büyükafşar K
Eur J Pharmacol; 2005 Mar; 510(1-2):135-42. PubMed ID: 15740734
[TBL] [Abstract][Full Text] [Related]
9. A Rho-kinase inhibitor, Y-27632, reduces cholinergic contraction but not neurotransmitter release.
Fernandes L; D'Aprile A; Self G; McGuire M; Sew T; Henry P; Goldie R
Eur J Pharmacol; 2006 Nov; 550(1-3):155-61. PubMed ID: 17010334
[TBL] [Abstract][Full Text] [Related]
10. Direct cardiac effects of a novel vesamicol receptor ligand, m-iodobenzyl-trozamicol, assessed in the canine isolated, blood-perfused heart preparations.
Sugiyama A; Lurie KG; Efange SM; Takehana S; Hashimoto K
J Cardiovasc Pharmacol; 1999 Dec; 34(6):843-7. PubMed ID: 10598128
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Y-27632, a rho-kinase inhibitor, as a bronchodilator in guinea pigs.
Iizuka K; Shimizu Y; Tsukagoshi H; Yoshii A; Harada T; Dobashi K; Murozono T; Nakazawa T; Mori M
Eur J Pharmacol; 2000 Oct; 406(2):273-9. PubMed ID: 11020491
[TBL] [Abstract][Full Text] [Related]
12. Reduction of hepatic ischemia/reperfusion-induced injury by a specific ROCK/Rho kinase inhibitor Y-27632.
Ikeda F; Terajima H; Shimahara Y; Kondo T; Yamaoka Y
J Surg Res; 2003 Feb; 109(2):155-60. PubMed ID: 12643858
[TBL] [Abstract][Full Text] [Related]
13. The effect of a Rho kinase inhibitor Y-27632 on superoxide production, aggregation and adhesion in human polymorphonuclear leukocytes.
Kawaguchi A; Ohmori M; Harada K; Tsuruoka S; Sugimoto K; Fujimura A
Eur J Pharmacol; 2000 Sep; 403(3):203-8. PubMed ID: 10973620
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibition by the Rho kinase inhibitor Y-27632 of the increases in contractility and Ca2+ transients induced by endothelin-1 in rabbit ventricular myocytes.
Chu L; Norota I; Endoh M
Naunyn Schmiedebergs Arch Pharmacol; 2005 Mar; 371(3):185-94. PubMed ID: 15900512
[TBL] [Abstract][Full Text] [Related]
15. Intracellular signal transduction modulating expression of plasminogen activator inhibitor-1 in adipocytes.
Goto D; Fujii S; Kaneko T; Furumoto T; Sugawara T; Tarikuz Zaman AK; Imagawa S; Dong J; Nakai Y; Mishima T; Sobel BE; Kitabatake A
Biochem Pharmacol; 2003 Jun; 65(11):1907-14. PubMed ID: 12781343
[TBL] [Abstract][Full Text] [Related]
16. The first demonstration of CGRP-immunoreactive fibers in canine hearts: coronary vasodilator, inotropic and chronotropic effects of CGRP in canine isolated, blood-perfused heart preparations.
Sugiyama A; Kobayashi M; Tsujimoto G; Motomura S; Hashimoto K
Jpn J Pharmacol; 1989 Aug; 50(4):421-7. PubMed ID: 2789300
[TBL] [Abstract][Full Text] [Related]
17. Cardiac safety profile of sildenafil: chronotropic, inotropic and coronary vasodilator effects in the canine isolated, blood-perfused heart preparations.
Lubna NJ; Nakamura Y; Cao X; Wada T; Izumi-Nakaseko H; Ando K; Sugiyama A
J Toxicol Sci; 2016; 41(6):739-744. PubMed ID: 27853102
[TBL] [Abstract][Full Text] [Related]
18. Rho-kinase inhibitor, Y-27632, has an antinociceptive effect in mice.
Büyükafşar K; Yalçin I; Kurt AH; Tiftik RN; Sahan-Firat S; Aksu F
Eur J Pharmacol; 2006 Jul; 541(1-2):49-52. PubMed ID: 16750189
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of optical isomers of cibenzoline, assessed in the canine isolated, blood-perfused papillary muscle and sinoatrial node preparations.
Takehana S; Sugiyama A; Hashimoto K
J Cardiovasc Pharmacol; 1999 Nov; 34(5):660-5. PubMed ID: 10547081
[TBL] [Abstract][Full Text] [Related]
20. Collagen gel contractility is enhanced in human endometriotic stromal cells: a possible mechanism underlying the pathogenesis of endometriosis-associated fibrosis.
Yuge A; Nasu K; Matsumoto H; Nishida M; Narahara H
Hum Reprod; 2007 Apr; 22(4):938-44. PubMed ID: 17204524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
